InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,583.56
(
0.59%
)
Post# of 4972155
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1249
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Friday, 05/05/2023 9:37:25 AM

Friday, May 05, 2023 9:37:25 AM

Post# of 4972155
(EQRX) $1.70 - 2 Cancer drugs awaiting approval in Europe with potential first approval in 2H of this year / Market cap $845 m trading massive below the cash balance of $1.4 billion ...Alphabet (Google) , Softbank , Blackrock and Vanguard alone holding over 100 million shares who paid around $10 per share ...


Aumolertinib: MAAs accepted for review by MHRA and EMA for EGFR-mutated NSCLC

Sugemalimab: MAAs accepted for review by MHRA and EMA for the first-line treatment of metastatic NSCLC in combination with chemotherapy

Ended 2022 with $1.4 billion in cash, cash equivalents and short-term investments; anticipate runway into 2028


Top Shareholders
https://www.cnbc.com/quotes/eqrx?tab=ownership

--
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up